News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Viatris Gains FDA Approval for First Generic Iron Sucrose Injection in the United States
Tuesday, August 12, 2025Viatris Inc has received approval from the United States Food and Drug Administration FDA for Iron Sucrose Injection USP an intravenous iron replacement therapy for treating iron deficiency anaemia IDA
Sartorius Stedim Biotech Partners with Nanotein Technologies to Boost Cell Therapy Manufacturing
Tuesday, August 12, 2025Sartorius Stedim Biotech a supplier to the biopharmaceutical industry has formed a partnership with Nanotein Technologies a company developing nextgeneration immune cell activation reagents
Galapagos NV Receives U.S. FDA RMAT Designation for GLPG5101 in Relapsed/Refractory Mantle Cell Lymphoma
Thursday, August 07, 2025Galapagos NV has announced that the US Food and Drug Administration FDA has granted Regenerative Medicine Advanced Therapy RMAT designation to its CART therapy candidate GLPG
Jazz Pharmaceuticals Receives U.S. FDA Approval for Modeyso™ as the First Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
Thursday, August 07, 2025Jazz Pharmaceuticals plc has announced that the US Food and Drug Administration FDA has granted accelerated approval for Modeyso dordaviprone This new treatment is intended for adults and children aged
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in All-Cash Deal
Wednesday, August 06, 2025SERB Pharmaceuticals a global specialty pharmaceutical company focused on rare diseases and medical emergencies has entered into a definitive agreement to acquire YmAbs Therapeutics Inc
Porosome Therapeutics Reports Major Breakthroughs in Alzheimer’s Disease Research
Wednesday, August 06, 2025Porosome Therapeutics Inc has announced significant progress in its novel neurological treatment platform aimed at modifying the course of Alzheimers Disease AD The companys approach
Clarametyx Biosciences Receives FDA Fast Track and QIDP Designations for CMTX-101 in Cystic Fibrosis
Tuesday, August 05, 2025Clarametyx Biosciences a clinicalstage biotechnology company focused on immuneenabling therapies and vaccines for chronic respiratory diseases has announced that the US Food and Drug Administration FDA
Innovent Secures FDA Approval to Begin Clinical Trials of Oral GLP-1R Agonist IBI3032
Tuesday, August 05, 2025Innovent Biologics has received approval from the US Food and Drug Administration FDA for its investigational new drug IND application to begin Phase clinical trials of IBI a novel oral GLP
FDA Approves New Indication for Novartis’ Leqvio® Allowing First-Line Use
Friday, August 01, 2025Novartis has announced that the US Food and Drug Administration FDA has approved an updated label for Leqvio inclisiran allowing it to be used as a firstline treatment The updated indication enables Leqvio
Altasciences and VoxCell BioInnovation Form Strategic Partnership to Support Preclinical Drug Development
Friday, August 01, 2025Altasciences a provider of integrated drug development services has announced a strategic collaboration with VoxCell BioInnovation a company specialising in D bioprinting and humanlike tissue models
